37 related articles for article (PubMed ID: 20409767)
1. Lack of access to insulin: undermining the Rights of the Child.
Heller O; Duperrex O; Jaffé PD; Goldhagen J; Abidha CA; Skelton A; Otani M; Heller Y; Vassalli JD; Beran D
Lancet Diabetes Endocrinol; 2024 Jul; 12(7):444-445. PubMed ID: 38824930
[No Abstract] [Full Text] [Related]
2. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN).
Gargallo-Fernández M; Escalada-San Martín J; Chico-Ballesteros A; Lecumberri-Pascual E; Tejera-Pérez C; Fernández-García JC; Rozas-Moreno P; Marco-Martínez A; Gómez-Peralta F; López-Fernández J
Endocrinol Diabetes Nutr (Engl Ed); 2022 Nov; 69(9):732-743. PubMed ID: 36404267
[TBL] [Abstract][Full Text] [Related]
3. [Advances in the treatment of pediatric type 1 diabetes].
Barrio Castellanos R
An Pediatr (Engl Ed); 2021 Feb; 94(2):65-67. PubMed ID: 33082083
[No Abstract] [Full Text] [Related]
4. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
5. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
[TBL] [Abstract][Full Text] [Related]
6. [Consensus document on continuous subcutaneous insulin infusion (CSII) treatment in paediatrics with type I diabetes].
Barrio Castellanos R; García Cuartero B; Gómez Gila A; González Casado I; Hermoso López F; Luzuriaga Tomás C; Oyarzabal Irigoyen M; Rica Etxebarria I; Rodríguez Rigual M; Torres Lacruz M;
An Pediatr (Barc); 2010 May; 72(5):352.e1-4. PubMed ID: 20409767
[TBL] [Abstract][Full Text] [Related]
7. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
8. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
